Showing results (61-70 of 417) with videos related to
Sort By:
Pageof 42
Molecular Biology International|September 11, 2015
Electrostatic Interactions between Complement Regulator CD46(SCR1-2) and Adenovirus Ad11/Ad21 Fiber Protein KnobCarl Z Chen, Ronald D Gorham, Zied Gaieb, et al.Frontiers in Physics|February 11, 2022
Systems Biology Modeling of the Complement System Under Immune Susceptible PathogensNehemiah T Zewde, Rohaine V Hsu, Dimitrios Morikis, et al.Seminars in Immunology|May 28, 2013
Complement inhibition in cancer therapyRuben Pio, Daniel Ajona, John D LambrisProceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Complement-activation fragment C4a mediates effector functions by binding as untethered agonist to protease-activated receptors 1 and 4HongBin Wang, Daniel Ricklin, John D LambrisMolecular Immunology|October 6, 2009
Recent developments in low molecular weight complement inhibitorsHongchang Qu, Daniel Ricklin, John D LambrisTrends in Immunology|September 6, 2021
C3-targeted therapy in periodontal disease: moving closer to the clinicGeorge Hajishengallis, Hatice Hasturk, John D Lambris, et al.Biopolymers|January 22, 2010
Solvation effects in calculated electrostatic association free energies for the C3d-CR2 complex and comparison with experimental dataAlexander S Cheung, Chris A Kieslich, Jianfeng Yang, et al.Seminars in Immunology|June 27, 2022
Complement component C3: A structural perspective and potential therapeutic implicationsBrian V Geisbrecht, John D Lambris, Piet GrosBiopolymers|September 19, 2007
Computational studies of CXCR1, the receptor of IL-8/CXCL8, using molecular dynamics and electrostaticsNicholas Huynh, Buddhadeb Mallik, Li Zhang, et al.BMC Biotechnology|July 20, 2019
Crosslinked flagella as a stabilized vaccine adjuvant scaffoldCasey M Gries, Rohith R Mohan, Dimitrios Morikis, et al.Pageof 42